Journal of the National Comprehensive Cancer Network

 
 

  • PET in Cervical Cancer Functional imaging techniques may predict survival based upon pre- and posttherapy scanning in patients with cervical cancer.
  • Targets, Trials, and Travails in Pancreas Cancer New potential targets in the treatment of pancreatic cancer may offer promise in fighting this formidable disease.
  • Early Detection and Biomarkers in Pancreatic Cancer Recent developments in the identification of serum biomarkers may aid in the early detection of pancreatic ductal adenocarcinoma.
  • Adjuvant Therapy for Stage II Colon Cancer Does the benefit of adjuvant therapy in stage II colon cancer outweigh the risks?
  • Evidence for Raloxifene as a Breast Cancer Risk Reduction Agent Postmenopausal women at increased risk for breast cancer may now have a new option for reducing risk that differs from standard approaches in important ways.
  • Counterpoint: The Case for Immediate Active Treatment Immediate active treatment may produce better outcomes than watchful waiting in patients with low risk prostate cancer.
  • Point: Active Surveillance for Favorable Risk Prostate Cancer Active surveillance of low risk prostate cancer can be effective with appropriate patient selection and reasonable criteria for intervention.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.